$166.36
arrow_drop_up1.35%Key Stats | |
---|---|
Open | $165.94 |
Prev. Close | $163.45 |
EPS | 9.59 |
Dividend | - |
Next Earnings Date | Dec 13, 2024 |
LOW | HIGH | |
---|---|---|
Day Range | 162.64 | 166.39 |
52 Week Range | 116.44 | 187.60 |
Ratios | |
---|---|
Revenue | - |
EPS | 9.59 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, ARCH, CYTH on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, SDIG, ARCH, CYTH on Behalf of Shareholders
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Arch Resources, Inc.
Arch Resources (ARCH) to Post Q2 Earnings: What's in Store? - Zacks Investment Research
Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product